These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9987752)

  • 1. [Use of a method of single-stranded DNA fragment conformation polymorphism (SSCP) for detecting resistance of Mycoplasm hominis to fluoroquinolones].
    Gushchin AE; Taganov KD; Topol' IuIu; Govorun VM
    Mol Gen Mikrobiol Virusol; 1998; (4):37-40. PubMed ID: 9987752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing.
    Charvalos E; Peteinaki E; Spyridaki I; Manetas S; Tselentis Y
    J Clin Lab Anal; 1996; 10(3):129-33. PubMed ID: 8731499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formation of M. hominis and A. laidlawii resistance to fluoroquinolones].
    Govorun VM; Gushchin AE; Ladygina VG; Abramycheva NIu; Topol' IuIu
    Mol Gen Mikrobiol Virusol; 1998; (3):16-9. PubMed ID: 9819821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of mutations in parC and gyrA in forming resistance of Mycoplasma hominis to fluoroquinolones].
    Gushchin AE; Ladygina VG; Govorun VM
    Mol Gen Mikrobiol Virusol; 1999; (4):19-24. PubMed ID: 10621934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of regions determining resistence to fluoroquinolones in genes gyrA and parC in clinical isolates of Mycoplasma hominis].
    Gushchin AE; Ladygina VG; Govorun VM; Taraskina AM; Savicheva AM
    Mol Gen Mikrobiol Virusol; 2000; (4):33-5. PubMed ID: 11186458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
    Beckmann L; Müller M; Luber P; Schrader C; Bartelt E; Klein G
    J Appl Microbiol; 2004; 96(5):1040-7. PubMed ID: 15078520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones.
    Bebear CM; Bové JM; Bebear C; Renaudin J
    Antimicrob Agents Chemother; 1997 Feb; 41(2):269-73. PubMed ID: 9021178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of fluoroquinolone (ciprofloxacin) resistance in Mycoplasma hominis in the presence of Hela cells].
    Momynaliev KT; Smirnova OV; Ladygina VG; Orlova VF; Akopian TA; Govorun VM
    Genetika; 2002 Jul; 38(7):922-8. PubMed ID: 12174584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli.
    Hänninen ML; Hannula M
    J Antimicrob Chemother; 2007 Dec; 60(6):1251-7. PubMed ID: 17911389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C; Hogan T; White P; Tapsall J
    Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A.
    Vashist J; Vishvanath ; Kapoor R; Kapil A; Yennamalli R; Subbarao N; Rajeswari MR
    Indian J Biochem Biophys; 2009 Apr; 46(2):147-53. PubMed ID: 19517991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR; Tapsall JW; White PA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients.
    Sinha S; Chattopadhyay S; Bhattacharya SK; Nair GB; Ramamurthy T
    Res Microbiol; 2004 Dec; 155(10):827-9. PubMed ID: 15567276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes.
    Casson N; Greub G
    Int J Antimicrob Agents; 2006 Jun; 27(6):541-4. PubMed ID: 16697560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
    Pasquali F; Rossi M; Manfreda G; Zanoni R
    Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of mutations in the A-subunit of Acholeplasma laidlawii PG-8B topoisomerase IV in formation of resistance to fluoroquinolones].
    Taganov KD; Gushchin AE; Abramycheva NIu; Govorun VM
    Mol Gen Mikrobiol Virusol; 2000; (2):30-3. PubMed ID: 10876765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp.
    Maurin M; Abergel C; Raoult D
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2098-105. PubMed ID: 11408229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the molecular mechanism of quinolone resistance in Shigellae spp].
    Zhu JY; Duan GC; Xi YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Mar; 25(3):245-7. PubMed ID: 15200940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
    Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
    Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.